Advancement of asthma management in the past decade.

Asthma, a chronic inflammatory airway disease, is one of the most common long-term conditions worldwide and can affect people of all ages. The Global Burden of Disease study estimated that 262 million people were living with asthma in 2019. Asthma accounts for about half a million deaths per year and is a major global economic burden in terms of both direct and indirect costs.1,2